An alternative investment firm specializing in providing financing solutions and strategic support to innovative companies in the life sciences and healthcare industries.

K2 HealthVentures

K2 HealthVentures (K2HV) is an alternative investment firm that provides flexible, long-term financing solutions to innovative private and public companies in the life sciences and healthcare industries.
 
We are healthcare specialists with deep domain expertise, and we understand both the opportunities and challenges that face venture-stage and growth-stage companies. Further, our flat organizational set-up enables nimble decision-making, and our evergreen fund structure allows us to be creative and adapt our facilities to a company’s specific needs over both the short and the long term. 

Over the last 4 years we have committed more than $1 billion in debt and equity capital to both private and public companies, and our team’s track record spans decades of investing in and supporting innovative life sciences and healthcare companies (with over $4 billion total investments in over 100 portfolio companies).

Surface Oncology

TScan Therapeutics

VBI Vaccines

Oncorus

Metacrine

Molecular Templates

Colorescience

Companion Medical

Inozyme

Aptinyx

Cricket Health

Elevation Oncology

Did you know that a recent survey shows that roughly a third of Medicare patients (both Traditional and Medicare Advantage) struggle to access primary care? We are proud to support HarmonyCares, a leading provider of value-based, in-home longitudinal care. This capital raise will help expand their footprint and develop new technology to drive clinical outcomes and patient satisfaction at scale.

As we enter 2024, our team would like to reflect on K2HV’s progress and accomplishments. Learn more in our Year End Letter:

This week Life Science Cares Boston launched a Health Equity Portfolio Co-Investment Program as part of its Anti-Poverty Strategy for Greater Boston. We are proud that our foundation is able to support LSC’s new grantmaking program aimed at addressing health inequities among low-income families and communities in the area.

Learn more: https://bit.ly/4aMDXnJ

#lifesciences #giveback #antipoverty

Thrilled to share our recent feature on NBC NEWS! 🌟 Explore the rise of Prescribed Pediatric Extended Care Centers (PPECs), or 'medical daycares,' across the U.S. These centers provide a haven for children with complex medical conditions, offering normalcy, play, and interaction under the watchful care of dedicated nurses. Spark Pediatrics is proud to be part of this positive movement, ensuring a nurturing environment for every child in our care. Watch the story here: https://lnkd.in/gtiijABX #PediatricCare #MedicalDaycare #NBCNewsFeature #SparkPediatrics

We’re #hiring a new Finance and Accounting Manager in Boston, Massachusetts. Apply today or share this post with your network.

Metric
Company Name	K2 HealthVentures
Symbol
MSH ID	COM:K2HV
Market	PRIVATE
Sector	Financial Services & Finance
Industry	Alternative Investment
Country	US
Stage
Employee Count	21
Website	k2hv.com
LinkedIn	k2healthventures
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

K2HV

COM:K2HV

K2 HealthVentures

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue